Marghani, B.H.; El-Adl, M.; Ateya, A.I.; Othman, B.H.; Ghamry, H.I.; Shukry, M.; Soliman, M.M.; Rizk, M.A.
The Potential Protective Effect and Underlying Mechanisms of Physiological Unconjugated Hyperbilirubinemia Mediated by UGT1A1 Antisense Oligonucleotide Therapy in a Mouse Model of Cyclosporine A-Induced Chronic Kidney Disease. Metabolites 2022, 12, 999.
https://doi.org/10.3390/metabo12100999
AMA Style
Marghani BH, El-Adl M, Ateya AI, Othman BH, Ghamry HI, Shukry M, Soliman MM, Rizk MA.
The Potential Protective Effect and Underlying Mechanisms of Physiological Unconjugated Hyperbilirubinemia Mediated by UGT1A1 Antisense Oligonucleotide Therapy in a Mouse Model of Cyclosporine A-Induced Chronic Kidney Disease. Metabolites. 2022; 12(10):999.
https://doi.org/10.3390/metabo12100999
Chicago/Turabian Style
Marghani, Basma H., Mohamed El-Adl, Ahmed I. Ateya, Basma H. Othman, Heba I. Ghamry, Mustafa Shukry, Mohamed Mohamed Soliman, and Mohamed Abdo Rizk.
2022. "The Potential Protective Effect and Underlying Mechanisms of Physiological Unconjugated Hyperbilirubinemia Mediated by UGT1A1 Antisense Oligonucleotide Therapy in a Mouse Model of Cyclosporine A-Induced Chronic Kidney Disease" Metabolites 12, no. 10: 999.
https://doi.org/10.3390/metabo12100999
APA Style
Marghani, B. H., El-Adl, M., Ateya, A. I., Othman, B. H., Ghamry, H. I., Shukry, M., Soliman, M. M., & Rizk, M. A.
(2022). The Potential Protective Effect and Underlying Mechanisms of Physiological Unconjugated Hyperbilirubinemia Mediated by UGT1A1 Antisense Oligonucleotide Therapy in a Mouse Model of Cyclosporine A-Induced Chronic Kidney Disease. Metabolites, 12(10), 999.
https://doi.org/10.3390/metabo12100999